Table 3.
Number of patients with (i) a substantial increase in acoustic hearing loss, (ii) a total loss of acoustic hearing, following short-electrode implantation
| Study | Number of patients implanted with a short cochlear implant |
Insertion depth of short cochlear implant (mm) (P = not specified but known to be partial) |
Manufacturer/ make of short cochlear implant |
No. of patients with substantial increase in acoustic hearing loss post-implantation |
No. of patients with total loss of acoustic hearing post-implantation (na = data not available) |
|---|---|---|---|---|---|
| Ilberg et al.,5 | 1 | 20 | MedEl Combi 40+ | 0 | 0 |
| Skarzynski et al.,31 | 26 | 26.4 | MedEl Combi 40/40+ | 5 | 5 |
| Gantz et al.,32 | 3 | 6 | Nucleus CI-24 (modification of) | 0 | 0 |
| 3 | 10 | Nucleus CI-24 (modification of) | 0 | 0 | |
| Skarzynski et al.,33 | 1 | 20 | MedEl Combi 40+ | 0 | 0 |
| Wilson et al.,34 | 1 | 20 | MedEl Combi 40+ | 0 | 0 |
| Gantz et al.,35 | 3 | 6 | Nucleus CI-24 (modification of) | 0 | 0 |
| 6 | 10 | Nucleus CI-24 (modification of) | 0 | 0 | |
| Gantz et al.,36 | 3 | 6 | Nucleus CI-24 (modification of) | 0 | 0 |
| 8 | 10 | Nucleus CI-24 (modification of) | 0 | 0 | |
| Gstoettner et al.,14 | 21 | 16–24 | MedEl Combi 40+/40+M | 4 | 3 |
| Kiefer et al.,37 | 14 | 19–24 | MedEl Combi 40+/40+M | 2 | 2 |
| James et al.,38 | 12 | 17–19 | Nucleus 24 contour advance | 6 | 3 |
| Kiefer et al.,9 | 13 | 19–24 | MedEl Combi 40+/40+M | 2 | 2 |
| Gantz et al.,10 | 48 | 10 | Nucleus Hybrid | 8 | 2 |
| Gstoettner et al.,39 | 23 | 18–24 | MedEl Combi 40+/40+M | 10 | 7 |
| James et al.,11 | 10 | 17 | Nucleus 24 contour advance | 3 | 3 |
| Lenarz et al.,12 | 4 | 16 | Nucleus Hybrid-L | 0 | 0 |
| Luetje et al.,40 | 13 | P | Nucleus Hybrid | 5 | 2 |
| Skarzynski et al.,41 | 10 | P | MedEl Combi 40+ | 2 | 1 |
| Berrettini et al.,42 | 8 | 25 | Nucleus 24 M-K | 6 | na |
| 11 | 19 | Nucleus 24 contour | 6 | na | |
| 11 | 17–19 | Nucleus 24 contour advance | 2 | na | |
| Total no. of patients implanted with a short cochlear implant |
253 | Total no. of patients | 61 | 30 | |
| Percentage of patients (%) | 24 | 13 |